Revvity (RVTY) Revenue & Revenue Breakdown
Revvity Revenue Highlights
Latest Revenue (Y)
$2.75B
Latest Revenue (Q)
$641.72M
Revvity Revenue by Period
Revvity Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $2.75B | -16.95% |
| 2022-12-31 | $3.31B | -34.64% |
| 2021-12-31 | $5.07B | 33.95% |
| 2020-12-31 | $3.78B | 31.18% |
| 2019-12-31 | $2.88B | 3.80% |
| 2018-12-31 | $2.78B | 23.08% |
| 2017-12-31 | $2.26B | 6.69% |
| 2016-12-31 | $2.12B | -6.49% |
| 2015-12-31 | $2.26B | 1.12% |
| 2014-12-31 | $2.24B | 3.28% |
| 2013-12-31 | $2.17B | 2.41% |
| 2012-12-31 | $2.12B | 10.09% |
| 2011-12-31 | $1.92B | 12.73% |
| 2010-12-31 | $1.70B | -5.95% |
| 2009-12-31 | $1.81B | -6.47% |
| 2008-12-31 | $1.94B | 8.40% |
| 2007-12-31 | $1.79B | 15.58% |
| 2006-12-31 | $1.55B | 4.92% |
| 2005-12-31 | $1.47B | -12.65% |
| 2004-12-31 | $1.69B | 9.90% |
| 2003-12-31 | $1.54B | 2.01% |
| 2002-12-31 | $1.50B | 13.15% |
| 2001-12-31 | $1.33B | -21.54% |
| 2000-12-31 | $1.70B | 24.37% |
| 1999-12-31 | $1.36B | -3.18% |
| 1998-12-31 | $1.41B | -3.62% |
| 1997-12-31 | $1.46B | 2.35% |
| 1996-12-31 | $1.43B | 0.54% |
| 1995-12-31 | $1.42B | 6.53% |
| 1994-12-31 | $1.33B | -50.61% |
| 1993-12-31 | $2.70B | - |
Revvity generated $2.75B in revenue during NA 2023, up -16.95% compared to the previous quarter, and up 99.01% compared to the same period a year ago.
Revvity Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-29 | $641.72M | -7.22% |
| 2024-06-30 | $691.68M | 6.43% |
| 2024-03-31 | $649.92M | -6.61% |
| 2023-12-31 | $695.90M | 3.75% |
| 2023-09-30 | $670.74M | -5.41% |
| 2023-06-30 | $709.07M | 5.07% |
| 2023-03-31 | $674.87M | -8.95% |
| 2022-12-31 | $741.21M | 4.13% |
| 2022-10-02 | $711.80M | -42.11% |
| 2022-06-30 | $1.23B | -2.37% |
| 2022-03-31 | $1.26B | -7.69% |
| 2021-12-31 | $1.36B | 16.94% |
| 2021-09-30 | $1.17B | -5.03% |
| 2021-06-30 | $1.23B | -6.06% |
| 2021-03-31 | $1.31B | -3.46% |
| 2020-12-31 | $1.35B | 40.52% |
| 2020-09-30 | $964.02M | 18.76% |
| 2020-06-30 | $811.72M | 24.42% |
| 2020-03-31 | $652.40M | -19.01% |
| 2019-12-31 | $805.50M | 13.94% |
| 2019-09-30 | $706.92M | -2.16% |
| 2019-06-30 | $722.52M | 11.37% |
| 2019-03-31 | $648.74M | -14.23% |
| 2018-12-31 | $756.35M | 12.17% |
| 2018-09-30 | $674.31M | -4.13% |
| 2018-06-30 | $703.36M | 9.22% |
| 2018-03-31 | $643.97M | 0.37% |
| 2017-12-31 | $641.63M | 15.76% |
| 2017-09-30 | $554.27M | 1.34% |
| 2017-06-30 | $546.96M | 6.39% |
| 2017-03-31 | $514.12M | -9.29% |
| 2016-12-31 | $566.77M | 3.41% |
| 2016-09-30 | $548.05M | -4.30% |
| 2016-06-30 | $572.67M | 6.31% |
| 2016-03-31 | $538.68M | -11.42% |
| 2015-12-31 | $608.12M | 7.93% |
| 2015-09-30 | $563.44M | -0.08% |
| 2015-06-30 | $563.91M | 7.02% |
| 2015-03-31 | $526.90M | -13.39% |
| 2014-12-31 | $608.39M | 12.24% |
| 2014-09-30 | $542.05M | -2.54% |
| 2014-06-30 | $556.17M | 4.56% |
| 2014-03-31 | $531.90M | -10.35% |
| 2013-12-31 | $593.28M | 13.16% |
| 2013-09-30 | $524.28M | -3.50% |
| 2013-06-30 | $543.30M | 7.50% |
| 2013-03-31 | $505.38M | -11.79% |
| 2012-12-31 | $572.92M | 12.42% |
| 2012-09-30 | $509.60M | -2.34% |
| 2012-06-30 | $521.79M | 2.13% |
| 2012-03-31 | $510.89M | -5.42% |
| 2011-12-31 | $540.19M | 19.05% |
| 2011-09-30 | $453.74M | -5.37% |
| 2011-06-30 | $479.49M | 7.06% |
| 2011-03-31 | $447.86M | -4.70% |
| 2010-12-31 | $469.97M | 12.13% |
| 2010-09-30 | $419.14M | -15.81% |
| 2010-06-30 | $497.84M | 7.04% |
| 2010-03-31 | $465.09M | -8.62% |
| 2009-12-31 | $508.99M | 16.46% |
| 2009-09-30 | $437.06M | 0.57% |
| 2009-06-30 | $434.57M | 0.70% |
| 2009-03-31 | $431.57M | 2.42% |
| 2008-12-31 | $421.37M | -16.58% |
| 2008-09-30 | $505.12M | -4.45% |
| 2008-06-30 | $528.64M | - |
Revvity generated $641.72M in revenue during Q3 2024, up -7.22% compared to the previous quarter, and up 90.50% compared to the same period a year ago.
Revvity Revenue Breakdown
Revvity Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Sep 24 | Mar 24 |
|---|---|---|
| Diagnostics | $383.13M | - |
| Life Sciences | $300.92M | - |
| Product | - | $565.75M |
| Service | - | $84.17M |
Latest
Revvity's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Diagnostics (56.01%), and Life Sciences (43.99%).
Revvity Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Sep 24 | Mar 24 |
|---|---|---|
| Americas | $302.32M | $294.35M |
| Europe | $182.04M | $178.56M |
| Asia | $199.69M | $177.00M |
Latest
Revvity's latest quarterly revenue breakdown by geography, as of Sep 24: Americas (44.20%), Asia (29.19%), and Europe (26.61%).
Revvity Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| IQV | IQVIA | $14.98B | $3.90B |
| LH | Laboratory Corporation of America | $12.16B | $3.28B |
| ICLR | ICON Public Limited Company | $8.12B | $2.09B |
| A | Agilent | $6.83B | $1.58B |
| CRL | Charles River Laboratories | $4.13B | $1.03B |
| MTD | Mettler-Toledo | $3.79B | $954.53M |
| IDXX | IDEXX Laboratories | $3.66B | $975.54M |
| WAT | Waters | $2.96B | $740.30M |
| RVTY | Revvity | $2.75B | $641.72M |
| QGEN | Qiagen | $1.97B | $458.80M |
| MEDP | Medpace | $1.89B | $533.32M |
| NEOG | Neogen | $924.22M | $216.96M |
| TWST | Twist Bioscience | $245.11M | $81.46M |
| OLK | Olink AB (publ) | $169.91M | $28.59M |
| ACRS | Aclaris Therapeutics | $31.25M | $4.35M |